Molecular Imaging of Epidermal Growth Factor Receptor in Colorectal Neoplasia Using Confocal Laser Endomicroscopy
NCT01372189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2012-02-01
Summary
The study aims to:
1. Achieve molecular imaging of EGFR in patients with colorectal neoplasia in vivo using confocal laser endomicroscopy.
2. Compare the results of in vivo EGFR-specific molecular imaging with CLE and ex vivo immunohistochemistry .
Conditions
- Colorectal Cancer
- Colorectal Adenoma
Sponsors & Collaborators
-
Shandong University
lead OTHER
Principal Investigators
-
Yanqing Li, PhD. MD. · Department of Gastroenterology, Qilu Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- China
Study Locations
More Related Trials
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Gasless Single-port Laparoscopic-assisted Radical Resection for Rectal Carcinoma
NCT03318185 ·Status: UNKNOWN ·Phase: NA
-
A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC
NCT03491709 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer
NCT06879197 ·Status: COMPLETED
-
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
NCT02419677 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer
NCT03986541 ·Status: COMPLETED
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
NCT05316103 ·Status: RECRUITING ·Phase: NA
-
EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
NCT03542799 ·Status: UNKNOWN ·Phase: PHASE1
-
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute
NCT05607186 ·Status: COMPLETED
-
SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
NCT06787183 ·Status: RECRUITING ·Phase: PHASE2
-
Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases
NCT06477718 ·Status: COMPLETED
-
the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer
NCT07080411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
NCT01671891 ·Status: UNKNOWN
-
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
NCT07269912 ·Status: NOT_YET_RECRUITING
-
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
NCT02502630 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficiency of Photodynamic Therapy for Rectal Cancer
NCT01872104 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
NCT05640726 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer
NCT06746298 ·Status: NOT_YET_RECRUITING
-
Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients
NCT05051592 ·Status: UNKNOWN
-
Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer
NCT05676190 ·Status: RECRUITING ·Phase: NA
-
Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer
NCT00835055 ·Status: WITHDRAWN
-
First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study
NCT06616259 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
NCT05485909 ·Status: UNKNOWN ·Phase: PHASE2
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING